Aspiriant LLC’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$345K Buy
2,224
+686
+45% +$103K 0.01% 290
2026
Q2
$220K Buy
+1,538
New +$216K 0.01% 367
2019
Q2
– Sell
-3,874
Closed -$266K – 232
2019
Q1
$266K Sell
3,874
-995
-20% -$65.4K 0.02% 194
2018
Q4
$291K Sell
4,869
-2,302
-32% -$155K 0.02% 186
2018
Q3
$551K Sell
7,171
-507
-7% -$37.4K 0.05% 149
2018
Q2
$531K Sell
7,678
-4,138
-35% -$291K 0.05% 153
2018
Q1
$807K Buy
+11,816
New +$841K 0.07% 121
2017
Q4
– Sell
-14,398
Closed -$905K – 109
2017
Q3
$905K Sell
14,398
-1,853
-11% -$112K 0.08% 113
2017
Q2
$969K Sell
16,251
-1,476
-8% -$87.5K 0.08% 115
2017
Q1
$1.06M Sell
17,727
-2,720
-13% -$162K 0.09% 114
2016
Q4
$1.14M Buy
20,447
+1,150
+6% +$61.9K 0.1% 102
2016
Q3
$1.05M Sell
19,297
-745
-4% -$39.9K 0.1% 102
2016
Q2
$1.11M Sell
20,042
-660
-3% -$35.1K 0.11% 101
2016
Q1
$1.13M Buy
+20,702
New +$998K 0.11% 99

Other funds holding EMR

Aspiriant LLC's EMR Position: Q3 2026 in Review

Aspiriant LLC increased its Emerson Electric (EMR) stake by 45% in Q3 2026, buying an estimated $103K and bringing the position to 2,224 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #290.

Aspiriant LLC first reported a position in EMR in Q1 2016 and has held it in 14 quarters since. The position peaked at $1.14M in Q4 2016. 717 funds tracked by Wall St. Rank hold EMR as of Q3 2026.

  • Aspiriant LLC held 2,224 shares of Emerson Electric worth $345K as of Q3 2026.
  • Aspiriant LLC bought 686 Emerson Electric shares in Q3 2026, an estimated $103K.
  • Emerson Electric made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #290 holding.
  • Aspiriant LLC first reported a position in Emerson Electric in Q1 2016 and has held it in 14 quarters since.
  • Aspiriant LLC's Emerson Electric position peaked at $1.14M in Q4 2016.
  • 717 funds tracked by Wall St. Rank held Emerson Electric as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.